PPD to Open Multipurpose Research Laboratory in China

Article

PPD, Inc. is opening a new laboratory in Suzhou, China, to support China-based biotech companies and Western pharmaceutical companies managing China research studies. The 67,000-square-foot facility in the Suzhou New District, Jiangsu Province, is expected to be fully operational in 2021. The company anticipates adding approximately 350 positions as a result of the expansion.

Christopher Fikry, MD, executive vice president of PPD Laboratories said, “Adding Suzhou to our central labs in Shanghai and Singapore expands the scope of our global laboratory footprint to help our customers advance drug development for patients across the world, particularly at a time when so much of our focus is on supporting trials aimed at developing vaccines and treatments for COVID-19.”

In addition to the new lab in Suzhou, PPD Laboratories includes bioanalytical labs in Middleton, Wisconsin, and Richmond, Virginia; GMP (good manufacturing practices) labs in Athlone, Ireland, and Middleton; central labs in Shanghai, China, Brussels, Belgium, Highland Heights, Kentucky, and Singapore; biomarker labs in Highland Heights and Richmond; and a vaccine sciences lab in Richmond.

To read the full release, click here.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.